114474-26-9

Basic information

• Product Name: 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE
• Synonyms: 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE;3-[5-(4-Piperidinyl)-1,2,4-oxadiazol-3-yl]pyridine
• CAS NO: 114474-26-9
• Molecular Formula: C₉H₇N₃O₂
• Molecular Weight: 230.27
• Mol File: 114474-26-9.mol
• Article Data: 11

Chemical Properties

• Melting Point: 80-83
• Boiling Point: 419.3 °C at 760 mmHg
• Flash Point: 207.4 °C
• Appearance: /
• Density: 1.184 g/cm³
• Vapor Pressure: 3.07E-07mmHg at 25°C
• Refractive Index: 1.55
• Storage Temp.: 2-8°C
• PKA: 12.54±0.50(Predicted)
• CAS DataBase Reference: 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE(114474-26-9)
• EPA Substance Registry System: 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE(114474-26-9)

Safety Data

• Hazard Codes: Xi,T
• Statements: 25
• Safety Statements: 45
• Hazardous Substances Data: 114474-26-9(Hazardous Substances Data)

Usage

General Description

3-(5-piperidin-4-yl-1,2,4-oxadiazol-3-yl)pyridine is a chemical compound with a molecular formula C13H15N5O. It is a heterocyclic compound containing a pyridine ring linked to a 1,2,4-oxadiazole ring with a piperidine substituent. 3-(5-PIPERIDIN-4-YL-1,2,4-OXADIAZOL-3-YL)PYRIDINE has potential applications in pharmaceutical and agrochemical industries due to its diverse biological activities, such as antifungal and antitumor properties. Its unique structural features make it an interesting candidate for further research and development in drug discovery and design.

InChI:InChI=1/C12H14N4O/c1-2-10(8-14-5-1)11-15-12(17-16-11)9-3-6-13-7-4-9/h1-2,5,8-9,13H,3-4,6-7H2

Upstream product

• 104-03-0 4-nitrobenzeneacetic acid 
• 676605-99-5 (Z)-2-(4'-nitrophenyl)-3-N,N-dimethylaminopropenal 
• 552846-17-0 tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-carboxylate 
• 586-78-7 para-nitrophenyl bromide 
• 18915-53-2 2-(4-nitrophenyl)-1,3-propanedial 
• 93072-94-7 p-Nitrophenylmalondialdehyde 

Downstream Products

• 1610874-68-4 N-(4-(1H-pyrazol-4-yl)phenyl)-3-(2-chlorophenyl)propanamide 
• 209959-26-2 tert-butyl 4-(4-aminophenyl)-1H-pyrazole-1-carboxylate 
• 1610875-33-6 tert-butyl 4-(4-(3-(2-chlorophenyl)propanamido)phenyl)-1H-pyrazole-1-carboxylate 
• 209959-25-1 tert-butyl 4-(4-nitrophenyl)-1H-pyrazole-1-carboxylate 
• 37921-15-6 1-methyl-4-(4-nitrophenyl)-1H-pyrazole 

Relevant articles and documents

Design, synthesis, and biologic evaluation of some novel N-arylpyrazole derivatives as cytotoxic agents

A novel series of N-arylpyrazole derivatives (5a-5d, 7a-7c) has been designed and synthesized via aromatic substitution reaction of N-nonsubstituted pyrazoles with 4-fluoronitrobenzene in the presence of base. The structures of these compounds were establ

CYCLIN-DEPENDENT KINASE INHIBITORS

Described herein are compounds and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, methods of treatment, and medical uses. The compounds described herein are modulators of cyclin-dependent kinases, and are useful in the treatment or alleviation of protein kinase associated disorders, including cancer, infectious diseases, autoimmune diseases, or cardiovascular diseases.

RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF

The present invention relates to a Rho-associated protein kinase inhibitor of Formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and use thereof for the prevention or treatment of a disease mediated by the Rho-associated protein kinase (ROCK).